Listing 1 - 10 of 16 | << page >> |
Sort by
|
Choose an application
Autophagy (also known as macroautophagy) is an evolutionarily conserved process by which cytoplasmic components are nonselectively enclosed within a double-membrane vesicle known as the autophagosome and delivered to the vacuole for degradation of toxic components and recycling of needed nutrients. This catabolic process is required for the adequate adaptation and response of the cell, and correspondingly the whole organism, to different types of stress including nutrient starvation or oxidative damage. Autophagy has been extensively investigated in yeasts and mammals but the identification of autophagy-related (ATG) genes in plant and algal genomes together with the characterization of autophagy-deficient mutants in plants have revealed that this process is structurally and functionally conserved in photosynthetic eukaryotes. Recent studies have demonstrated that autophagy is active at a basal level under normal growth in plants and is upregulated during senescence and in response to nutrient limitation, oxidative stress, salt and drought conditions and pathogen attack. Autophagy was initially considered as a non-selective pathway, but numerous observations mainly obtained in yeasts revealed that autophagy can also selectively eliminate specific proteins, protein complexes and organelles. Interestingly, several types of selective autophagy appear to be also conserved in plants, and the degradation of protein aggregates through specific adaptors or the delivery of chloroplast material to the vacuole via autophagy has been reported. This research topic aims to gather recent progress on different aspects of autophagy in plants and algae. We welcome all types of articles including original research, methods, opinions and reviews that provide new insights about the autophagy process and its regulation.
Botany --- Autophagy. --- Lipid degradation --- selective autophagy --- pexophagy --- algae --- Plants
Choose an application
Autophagy (also known as macroautophagy) is an evolutionarily conserved process by which cytoplasmic components are nonselectively enclosed within a double-membrane vesicle known as the autophagosome and delivered to the vacuole for degradation of toxic components and recycling of needed nutrients. This catabolic process is required for the adequate adaptation and response of the cell, and correspondingly the whole organism, to different types of stress including nutrient starvation or oxidative damage. Autophagy has been extensively investigated in yeasts and mammals but the identification of autophagy-related (ATG) genes in plant and algal genomes together with the characterization of autophagy-deficient mutants in plants have revealed that this process is structurally and functionally conserved in photosynthetic eukaryotes. Recent studies have demonstrated that autophagy is active at a basal level under normal growth in plants and is upregulated during senescence and in response to nutrient limitation, oxidative stress, salt and drought conditions and pathogen attack. Autophagy was initially considered as a non-selective pathway, but numerous observations mainly obtained in yeasts revealed that autophagy can also selectively eliminate specific proteins, protein complexes and organelles. Interestingly, several types of selective autophagy appear to be also conserved in plants, and the degradation of protein aggregates through specific adaptors or the delivery of chloroplast material to the vacuole via autophagy has been reported. This research topic aims to gather recent progress on different aspects of autophagy in plants and algae. We welcome all types of articles including original research, methods, opinions and reviews that provide new insights about the autophagy process and its regulation.
Botany --- Autophagy. --- Lipid degradation --- selective autophagy --- pexophagy --- algae --- Plants
Choose an application
Autophagy (also known as macroautophagy) is an evolutionarily conserved process by which cytoplasmic components are nonselectively enclosed within a double-membrane vesicle known as the autophagosome and delivered to the vacuole for degradation of toxic components and recycling of needed nutrients. This catabolic process is required for the adequate adaptation and response of the cell, and correspondingly the whole organism, to different types of stress including nutrient starvation or oxidative damage. Autophagy has been extensively investigated in yeasts and mammals but the identification of autophagy-related (ATG) genes in plant and algal genomes together with the characterization of autophagy-deficient mutants in plants have revealed that this process is structurally and functionally conserved in photosynthetic eukaryotes. Recent studies have demonstrated that autophagy is active at a basal level under normal growth in plants and is upregulated during senescence and in response to nutrient limitation, oxidative stress, salt and drought conditions and pathogen attack. Autophagy was initially considered as a non-selective pathway, but numerous observations mainly obtained in yeasts revealed that autophagy can also selectively eliminate specific proteins, protein complexes and organelles. Interestingly, several types of selective autophagy appear to be also conserved in plants, and the degradation of protein aggregates through specific adaptors or the delivery of chloroplast material to the vacuole via autophagy has been reported. This research topic aims to gather recent progress on different aspects of autophagy in plants and algae. We welcome all types of articles including original research, methods, opinions and reviews that provide new insights about the autophagy process and its regulation.
Botany --- Lipid degradation --- selective autophagy --- pexophagy --- algae --- Plants --- Autophagy.
Choose an application
ln tumors, there is a lactate and an oxygen gradient. The latter is responsible for the formation of two distinct metabolic phenotypes: oxidative and glycolytic cancer cells. A symbiosis based on the exchange of lactate exists between these two metabolic phenotypes. Lactate therefore plays a key role in cancer metabolism. On the other hand, cancer cell survival depends on the activation of autophagy, a catabolic pathway that generates biosynthetic precursors by recycling macromolecules les and intracellular organelles. ln this undergraduate thesis, we sought to establish a link between the oxidative pathway of lactate and autophagy in oxidative cancer cells. Specifically, we focused on lactate dehydrogenase B (LDHB), a key player in the lactate pathway. Our experimental data indicate that LDHB is responsible for maintaining basal autophagy in oxidative cancer cells. Furthermore, our work shows that LDHB exerts a post transcriptional control and modulates the expression and activity of prolylhydroxy lase 2 (PHD2), an enzyme responsible for the hydroxylation and hydroxylation-mediated degradation of the HIF-la subunit of HIF-1. Our observations indicate that this control is twofold: (i) LDHB stabilizes the express ion of PHD2; and (ii) the enzymatic activity of LDHB produces pyruvate capable of inhibiting the activity of PHD2.We therefore propose LDHB as a new potential therapeutic target, the inhibition of which is able to black autophagy in oxidative cancer cells, the activity of transcription factor HIF-1 and, consequently, survival and, potentially, HIF-1-induced tumor angiogenesis. Au sein des tumeurs, il existe un gradient de lactate et un gradient d'oxygène. Ce dernier est responsable de la formation de deux phénotypes métaboliques distincts : les cellules cancéreuses oxydatives et glycolytiques. Une symbiose basée sur l'échange de lactate existe entre ces deux phénotypes métaboliques. Le lactate exerce donc un rôle clé dans le métabolisme cancéreux. D'autre part, la survie des cellules cancéreuses nécessite l'activation de !'autophagie, un processus catabolique permettant de générer des précurseurs biosynthétiques par le recyclage de macromolécules et d'organelles intracellulaires. Au cours de ce mémoire, nous avons cherché à établir un lien entre la voie oxydative du lactate et !'autophagie dans les cellules cancéreuses oxydatives. Plus particulièrement, nous nous sommes intéressés à la lactate déshydrogénase B (LDHB), un des acteurs clés de la voie du lactate. Les résultats de nos recherches indiquent que la LDHB est responsable du maintien de !'autophagie basale des cellules cancéreuses oxydatives. D'autre part, nos travaux montrent que la LDHB exerce un contrôle post transcriptionnel et module l'expression et l'activité de la prolylhydroxylase 2 (PHD2), une enzyme responsable de l'hydroxylation précédant la dégradation de la sous-unité HIF-la d'HIF-1. Nos observationsindiquent que ce contrôle est double : (i) la LDHB stabiliserait l'expression de la PHD2 ; et (ii) l'activité enzymatique de la LDHB produit du pyruvate capable d'inhiber l'activité de la PHD2.Nous proposons donc la LDHB comme une nouvelle cible thérapeutique potentielle dont l'inhibition est capable de bloquer !'autophagie des cellules cancéreuses oxydatives, l'activité du facteur de transcription HIF-1 et, par conséquent, la survie cellulaire et, potentiellement, l'angiogenèse tumorale qui dépend del'activité d'HIF-1.
Lactate Dehydrogenase B Deficiency --- Autophagy --- PHD2 protein, rat
Choose an application
Plasma cells (PCs) are terminally differentiated B-cells producing large amounts of immunoglobulins (Ig). In humans, most of circulating Ig are produced by bone marrow plasma cells. PCs differentiate from activated naïve or memory B-cells usually activated by specific antigens. It is still controversial whether the regulation of PCs numbers and the “active” in vivo Ig diversity depend or not on non-specific reactivation of B-cells during infections. Depending on the stimulus (T-independent/T-dependent antigen, cytokines, partner cells) and B-cell types (naïve or memory, circulating or germinal center, lymph nodes or spleen, B1 or B2...), both the phenotype and isotype of PCs differ suggesting that PC diversity is either linked to B-cell diversity or to the type of stimulus or to both. Knowledge of the mechanisms supporting PC diversity has important consequences for the management of i) plasma cell neoplasia such as Multiple Myeloma and Waldenström's Macroglobulinemia, ii) vaccine protection against pathogens and iii) auto-immune diseases.
IL21 --- Autoimmunity --- differentiation --- Cell Cycle --- B-cell --- Plasma cell --- Myeloma --- Autophagy --- B1
Choose an application
Plasma cells (PCs) are terminally differentiated B-cells producing large amounts of immunoglobulins (Ig). In humans, most of circulating Ig are produced by bone marrow plasma cells. PCs differentiate from activated naïve or memory B-cells usually activated by specific antigens. It is still controversial whether the regulation of PCs numbers and the “active” in vivo Ig diversity depend or not on non-specific reactivation of B-cells during infections. Depending on the stimulus (T-independent/T-dependent antigen, cytokines, partner cells) and B-cell types (naïve or memory, circulating or germinal center, lymph nodes or spleen, B1 or B2...), both the phenotype and isotype of PCs differ suggesting that PC diversity is either linked to B-cell diversity or to the type of stimulus or to both. Knowledge of the mechanisms supporting PC diversity has important consequences for the management of i) plasma cell neoplasia such as Multiple Myeloma and Waldenström's Macroglobulinemia, ii) vaccine protection against pathogens and iii) auto-immune diseases.
IL21 --- Autoimmunity --- differentiation --- Cell Cycle --- B-cell --- Plasma cell --- Myeloma --- Autophagy --- B1
Choose an application
Plasma cells (PCs) are terminally differentiated B-cells producing large amounts of immunoglobulins (Ig). In humans, most of circulating Ig are produced by bone marrow plasma cells. PCs differentiate from activated naïve or memory B-cells usually activated by specific antigens. It is still controversial whether the regulation of PCs numbers and the “active” in vivo Ig diversity depend or not on non-specific reactivation of B-cells during infections. Depending on the stimulus (T-independent/T-dependent antigen, cytokines, partner cells) and B-cell types (naïve or memory, circulating or germinal center, lymph nodes or spleen, B1 or B2...), both the phenotype and isotype of PCs differ suggesting that PC diversity is either linked to B-cell diversity or to the type of stimulus or to both. Knowledge of the mechanisms supporting PC diversity has important consequences for the management of i) plasma cell neoplasia such as Multiple Myeloma and Waldenström's Macroglobulinemia, ii) vaccine protection against pathogens and iii) auto-immune diseases.
IL21 --- Autoimmunity --- differentiation --- Cell Cycle --- B-cell --- Plasma cell --- Myeloma --- Autophagy --- B1
Choose an application
Loss of muscle mass and increased fibrosis characterize both sarcopenia of aging and muscular dystrophy. Research is increasingly showing that these two conditions also share several pathophysiological mechanisms, including mitochondrial dysfunction, increased apoptosis, abnormal modulation of autophagy, decline in satellite cells, increased generation of reactive oxygen species, and abnormal regulation of signaling and stress response pathways. This Research Topic will cover several mechanisms involved in aging and dystrophic sarcopenia and explore the therapeutic potential of various strategies for intervention.
Aging sarcopenia --- muscular dystrophy --- Mitochondrial dysfunction --- therapy --- skeletal muscle --- Autophagy --- Animal Models --- Apoptosis --- satellite cells --- muscle imaging
Choose an application
Unfolded protein response (UPR) is a cellular adaptive response for restoring endoplasmic reticulum (ER) homeostasis in response to ER stress. Perturbation of the UPR and failure to restore ER homeostasis inevitably leads to diseases. It has now become evident that perturbation of the UPR is the cause of many important human diseases such as neurodegenerative diseases, cystic fibrosis, diabetes and cancer. It has recently emerged that virus infections can trigger the UPR but the relationship between virus infections and host UPR is intriguing. On one hand, UPR is harmful to the virus and virus has developed means to subvert the UPR. On the other hand, virus exploits the host UPR to assist in its own infection, gene expression, establishment of persistence, reactivation from latency and to evade the immune response. When this delicate balance of virus-host UPR interaction is broken down, it may cause diseases. This is particularly challenging for viruses that establish a chronic infection to maintain this balance. Each virus interacts with the host UPR in a different way to suit their life style and how the virus interacts with the host UPR can define the characteristic of a particular virus infection. Understanding how a particular virus interacts with the host UPR may pave the way to the design of a new class of anti-viral that targets this particular pathway to skew the response towards anti-virus. This knowledge can also be translated into the clinics to help re-design oncolytic virotherapy and gene therapy. In this research topic we aimed to compile a collection of focused review articles, original research articles, commentary, opinion, hypothesis and methods to highlight the current advances in this burgeoning area of research, in an attempt to provide an in-depth understanding of how viruses interact with the host UPR, which may be beneficial to the future combat of viral and human diseases.
Virus diseases. --- Viruses. --- ERAD --- virus-host interaction --- innate immunity --- Gene Therapy --- Pathogenesis --- Endoplasmic Reticulum Stress --- Unfolded Protein Response --- Autophagy
Choose an application
Loss of muscle mass and increased fibrosis characterize both sarcopenia of aging and muscular dystrophy. Research is increasingly showing that these two conditions also share several pathophysiological mechanisms, including mitochondrial dysfunction, increased apoptosis, abnormal modulation of autophagy, decline in satellite cells, increased generation of reactive oxygen species, and abnormal regulation of signaling and stress response pathways. This Research Topic will cover several mechanisms involved in aging and dystrophic sarcopenia and explore the therapeutic potential of various strategies for intervention.
Aging sarcopenia --- muscular dystrophy --- Mitochondrial dysfunction --- therapy --- skeletal muscle --- Autophagy --- Animal Models --- Apoptosis --- satellite cells --- muscle imaging
Listing 1 - 10 of 16 | << page >> |
Sort by
|